China Sky One Medical announced SFDA approval for another four new topically applied products. China Sky One put the expected market for each product between $2 million and $2.4 million. China Sky One has become a virtual press release industry, all by itself. Earlier this month, it announced the approval of five new patch products. Then, one week later, China Sky One acquired Peng Lai Jin Chuang Company, bringing along its portfolio of 20 approved products to put under the care of China Sky One. More details...

Stock Symbol: (AMEX: CSY)